Jeremy Schmitz, MD
Sports Medicine · Warrensburg, MONPI 1982017927
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,122 of the $3,872 with a category attached, or 80.6%. 24 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 38.0% of the total. 2025 is the largest year on record at $1,651, 2.6 times the $638 reported in 2019.
Across 132 payments — averaging $29.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$1K
- Amgen$1K
- Daiichi Sankyo Inc.$125
- Lilly USA, LLC$123
- Radius Health, Inc.$116
- Novo Nordisk$76
- plus $537 from 18 others
What the payments were for
- Travel & lodging$75019%
- Food & beverage$3,12281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 15 | $1,470 |
| Amgen(2 entities) | 71 | $1,425 |
| Daiichi Sankyo Inc. | 1 | $125 |
| Lilly USA, LLC | 6 | $123 |
| Radius Health, Inc. | 5 | $116 |
| Novo Nordisk | 5 | $76 |
| Johnson & Johnson | 3 | $67 |
| Titan Surgical Group, LLC | 2 | $65 |
| Axsome Therapeutics, Inc. | 3 | $49 |
| Bioventus LLC | 2 | $40 |
| Avanos Medical | 2 | $38 |
| Sonex Health, Inc. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Boehringer Ingelheim | 2 | $29 |
| Fidia Pharma USA Inc. | 1 | $26 |
| AbbVie | 1 | $25 |
| Amarin Pharma, Inc. | 2 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Kerecis Limited | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Novartis | 1 | $14 |
| GSK | 1 | $13 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$936
- Prolia$356
- EVENITY$247
- INJECTAFER$125
How this compares
$3,872 in reported general payments places this provider in the 60th percentile of 127 sports medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 17 | $679 |
| Gabapentin | 56 | $668 |
| Baclofen | 12 | $198 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $180 |
| Naproxen | 12 | $85 |
| Meloxicam | 31 | $70 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Warrensburg
- Drew GloverWarrensburg$8K
- Kristin OliverColumbia$209K
- Steven DefrodaColumbia$101K
- Clayton NuelleColumbia$89K
- Justin DragerColumbia$78K
- Derrick KnapikSaint Louis$72K
- Shawn SahotaColumbia$69K
- James StannardColumbia$68K
- Joshua HamannColumbia$57K
- Jeffrey KlottColumbia$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.